Anti-inflammatory mechanism of ginseng saponins in activated microglia

Journal of Neuroimmunology

Volumn 209, Issue 1-2, 2009, Pages 40-49

  Park, Jin Sun ^a   Park, Eun Mi ^b   Kim, Dong Hyun ^c   Jung, Kangsik ^c   Jung, Ji Sun ^a   Lee, Eun Jung ^a   Hyun, Jin Won ^d   Kang, Jihee Lee ^b   Kim, Hee Sun ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Kyung Hee University   (South Korea)

^d Jeju National University School of Medicine   (South Korea)

Author keywords

Cytokine; Ginseng saponin; iNOS; Microglia; Signaling pathway

Indexed keywords

CYTOKINE; GINSENG EXTRACT; GINSENG SAPONIN; GINSENOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KOREA RED GINSENG EXTRACT; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; ENCEPHALITIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LOW DRUG DOSE; MALE; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; DRUGS, CHINESE HERBAL; ENCEPHALITIS; GINSENOSIDES; GLIOSIS; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICROGLIA; NEURODEGENERATIVE DISEASES; NITRIC OXIDE SYNTHASE TYPE II; RATS; SAPONINS; SIGNAL TRANSDUCTION;

EID: 64549126462     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.01.020     Document Type: Article

References (53)

1. Bae E.A., Han M.J., Choo M.K., Park S.Y., and Kim D.H. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 25 (2002) 58-63
2. Bae E.A., Han M.J., Shin Y.W., and Kim D.H. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biol. Pharm. Bull. 29 (2006) 1862-1867
3. Bae E.A., Kim E.J., Park J.S., Kim H.S., Ryu J.H., and Kim D.H. Ginsenoside Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-γ-stimulated BV-2 microglial cells. Planta Med. 72 (2006) 627-633
4. Benishin C.G. Actions of ginsenoside Rb1 on choline uptake in central cholinergic nerve endings. Neurochem. Int. 21 (1992) 1-5
5. Bhat N.R., Zhang P., Lee J.C., and Hogan E.L. Extracellular signal regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18 (1998) 1633-1641
6. Block M.L., and Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76 (2005) 77-98
7. Block M.L., Zecca L., and Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev., Neurosci. 8 (2007) 57-69
8. Blumenthal M. Asian ginseng: potential therapeutic uses. Adv. Nurse Pract. 2 (2001) 26-28
9. Bocchini V., Mazzolla R., Barluzzi R., Blasi E., Sick P., and Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J. Neurosci. Res. 31 (1992) 616-621
10. Cha H.Y., Park J.H., Hong J.T., Yoo H.S., Song S., Hwang B.Y., Eun J.S., and Oh K.W. Anxiolytic-like effects of ginsenosides on the elevated plus-maze model in mice. Biol. Pharm. Bull. 28 (2005) 1621-1625
11. Chaturvedi R.K., and Beal M.F. PPAR: a therapeutic target in Parkinson's disease. J. Neurochem. 106 (2008) 506-518
12. Elijaschewitsch E., Witting A., Mawrin C., Lee T., Schmidt P.M., Wolf S., Hoertnagl H., Raine C.S., Schneider-Stock R., Nitsch R., and Ullrich O. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49 (2006) 67-79
13. Fan L.W., Pang Y., Lin S., Tien L.T., Ma T., Rhodes P.G., and Cai Z. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J. Neurosci. Res. 82 (2005) 71-82
14. Feldman H.H. Atlas of Alzheimer's disease (2007), Informa, UK 71-81
15. Hasegawa H., Sung J.H., and Huh J.D. Ginseng intestinal bacteria metabolite IH901 as a new antimetastatic agent. Arch. Pharm. Res. 20 (1997) 539-544
16. Hornykiewicz O., and Kish S.J. Biochemical pathphysiology of Parkinson's disease. Adv. Neurol. 45 (1987) 19-34
17. Joo S.S., and Lee D.I. Potential effects of microglial activation induced by ginsenoside Rg3 in rat primary culture: enhancement of type A macrophage scavenger receptor expression. Arch. Pharm. Res. 28 (2005) 1164-1169
18. Jung S.H., Woo M.S., Kim S.Y., Kim W.K., Hyun J.W., Kim E.J., Kim D.H., and Kim H.S. Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells. Int. J. Cancer 118 (2006) 490-497
19. Keum Y.S., Han S.S., Chun K.S., Park K.K., Park J.H., Lee S.K., and Surh Y.J. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat. Res. 523-4 (2003) 75-85
20. Kim W.K., and Ko K.H. Potentiation of N-methyl-D-aspartate-mediated neurotoxicity by immunostimulated murine microglia. J. Neurosci. Res. 54 (1998) 17-26
21. Kim S.U., and de Vellis J. Microglia in health and disease. J. Neurosci. Res. 81 (2005) 302-313
22. Kim Y.C., Kim S.R., Markelonis G.J., and Oh T.H. Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate induced neurodegeneration. J. Neurosci. Res. 53 (1998) 426-432
23. Kim W.Y., Kim J.M., Han S.B., Lee S.K., Kim N.D., Park M.K., Kim C.K., and Park J.H. Steaming of ginseng at high temperature enhances biological activity. J. Nat. Prod. 63 (2000) 1702-1704
24. Kim J.H., Cho S.Y., Lee J.H., Jeong S.M., Yoon I.S., Lee B.H., Lee J.H., Pyo M.K., Lee S.M., Chung J.M., Kim S., Rhim H., Oh J.W., and Nah S.Y. Neuroprotective effects of ginsenoside Rg3 against homocystein-induced excitotoxicity in rat hippocampus. Brain Res. 1136 (2007) 190-199
25. Kim S.Y., Kim D.H., Han S.J., Hyun J.W., and Kim H.S. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Biochem. Pharmacol. 74 (2007) 1642-1651
26. 2+ channel-mediated cell death in rat cortical neurons. Biochem. Biophys. Res. Commun. 365 (2008) 399-405
27. Kitagawa I., Yoshikawa M., Yoshihara M., Hayashi T., and Taniyama T. Chemical studies of crude drugs (1). Constituents of Ginseng radix rubra. Yakugaku Zasshi 103 (1983) 612-622
28. Lee H.U., Bae E.A., Han M.J., and Kim D.H. Hepatoprotective effect of 20(S)-ginsenoside Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tetra-butyl hydroperoxide-induced liver injury. Biol. Pharm. Bull. 28 (2005) 1992-1994
29. Lindberg C., Crisby M., Winblad B., and Schultzberg M. Effects of statins on microglia. J. Neurosci. Res. 82 (2005) 10-19
30. McGeer P.L., and McGeer E.G. NSAIDS and Alzheimer's disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 28 (2007) 639-647
31. Nah S.Y., Kim D.H., and Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system?. CNS Drug Rev. 13 (2007) 381-404
32. Otey C.A., Boukhelifa M., and Maness P. B35 neuroblastoma cells: an easily transfected, cultured cell model of central nervous system neurons. Methods Cell Biol. 44 (2003) 287-304
33. Pahl H.L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 186 (1999) 853-866
34. Park E.K., Choo M.K., Oh J.K., Ryu J.H., and Kim D.H. Ginsenoside Rh2 reduces ischemic brain injury in rats. Biol. Pharm. Bull. 27 (2004) 433-436
35. Park E.K., Shin Y.W., Lee H.U., Kim S.S., Lee Y.C., Lee B.Y., and Kim D.H. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosynthesis of RAW264.7 cells induced by lipopolysaccharide. Biol. Pharm. Bull. 28 (2005) 652-656
36. Park J.S., Woo M.S., Kim D.H., Hyun J.W., Kim W.K., Lee J.C., and Kim H.S. Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglial cells. J. Pharmacol. Exp. Ther. 320 (2007) 1237-1245
37. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., and Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55 (2007) 453-462
38. Radad K., Gille G., Liu L., and Rausch W.D. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J. Pharmacol. Sci. 100 (2006) 175-186
39. Ranaivo H.R., Craft J.M., Hu W., Guo L., Wing L.K., Van Eldik L.J., and Watterson D.M. Glia as a therapeutic target: selective suppression of human amyloid-β-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J. Neurosci. 26 (2006) 662-670
40. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 (2002) 279-291
41. Rudakewich M., Ba F., and Benishin C.G. Neurotrophic and neuroprotective actions of ginsenoside Rb1 and Rg1. Planta Med. 67 (2001) 533-537
42. Shin Y.W., Bae E.A., and Kim D.H. Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model. Arch. Pharm. Res. 29 (2006) 685-690
43. Streit W.J., Conde J.R., Fendrick S.E., Flanary B.E., and Mariani C.L. Role of microglia in the central nervous system's immune response. Neurol. Res. 27 (2005) 685-691
44. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., and Kuno R. Tumor necrosis factor-α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281 (2006) 21362-21368
45. Tian J., Fu F., Geng M., Jiang Y., Yang J., Jiang W., Wang C., and Liu K. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci. Lett. 374 (2005) 92-97
46. Trinh H.T., Han S.J., Kim S.W., Lee Y.C., and Kim D.H. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J. Microbiol. Biotechnol. 17 (2007) 1127-1133
47. Tripanichkul W., Sripanichkulchai K., and Finkelstein D.I. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication. Brain Res. 1084 (2006) 28-37
48. Wang L.C., Wang B., Ng S.Y., and Lee T.F. Effects of ginseng saponins on beta-amyloid-induced amnesia in rats. J. Enthopharmacol. 103 (2006) 103-108
49. Woo M.S., Jang P.G., Park J.S., Kim W.K., Joh T.H., and Kim H.S. Selective modulation of lipopolysaccharide-stimulated cytokine expression and mitogen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells. Mol. Brain Res. 113 (2003) 86-96
50. Woo M.S., Park J.S., Choi I.Y., Kim W.K., and Kim H.S. Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. J. Neurochem. 106 (2008) 770-780
51. Wu C.F., Bi X.L., Yang J.Y., Zhan J.Y., Dong Y.X., Wang J.H., Wang J.M., Zhang R., and Li X. Differential effects of ginsenosides on NO and TNF-α production by LPS-activated N9 microglia. Int. Immunopharmacol. 7 (2007) 313-320
52. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease: a double-edged sword. Neuron 35 (2002) 419-432
53. Yun T.K. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat. Res. 523/524 (2003) 63-74